Human aldehyde oxidase (hAOX1): structure determination of the Moco-free form of the natural variant G1269R and biophysical studies of single nucleotide polymorphisms.


Journal

FEBS open bio
ISSN: 2211-5463
Titre abrégé: FEBS Open Bio
Pays: England
ID NLM: 101580716

Informations de publication

Date de publication:
05 2019
Historique:
received: 19 02 2019
accepted: 21 02 2019
pubmed: 16 4 2019
medline: 13 11 2019
entrez: 16 4 2019
Statut: ppublish

Résumé

Human aldehyde oxidase (hAOX1) is a molybdenum enzyme with high toxicological importance, but its physiological role is still unknown. hAOX1 metabolizes different classes of xenobiotics and is one of the main drug-metabolizing enzymes in the liver, along with cytochrome P450. hAOX1 oxidizes and inactivates a large number of drug molecules and has been responsible for the failure of several phase I clinical trials. The interindividual variability of drug-metabolizing enzymes caused by single nucleotide polymorphisms (SNPs) is highly relevant in pharmaceutical treatments. In this study, we present the crystal structure of the inactive variant G1269R, revealing the first structure of a molybdenum cofactor (Moco)-free form of hAOX1. These data allowed to model, for the first time, the flexible Gate 1 that controls access to the active site. Furthermore, we inspected the thermostability of wild-type hAOX1 and hAOX1 with various SNPs (L438V, R1231H, G1269R or S1271L) by CD spectroscopy and ThermoFAD, revealing that amino acid exchanges close to the Moco site can impact protein stability up to 10 °C. These results correlated with biochemical and structural data and enhance our understanding of hAOX1 and the effect of SNPs in the gene encoding this enzyme in the human population. ENZYMES: Aldehyde oxidase (EC1.2.3.1); xanthine dehydrogenase (EC1.17.1.4); xanthine oxidase (EC1.1.3.2). DATABASES: Structural data are available in the Protein Data Bank under the accession number 6Q6Q.

Identifiants

pubmed: 30985987
doi: 10.1002/2211-5463.12617
pmc: PMC6487702
doi:

Substances chimiques

Coenzymes 0
Metalloproteins 0
Molybdenum Cofactors 0
Pteridines 0
molybdenum cofactor ATN6EG42UQ
AOX1 protein, human EC 1.2.3.1
Aldehyde Oxidase EC 1.2.3.1

Banques de données

PDB
['6Q6Q', '4UHW', '4UHX', '3UNC', '4YRW', '5EPG']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

925-934

Informations de copyright

© 2019 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.

Références

Coord Chem Rev. 2011 May 1;255(9-10):1179-1205
pubmed: 21516203
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W375-83
pubmed: 17452350
Hum Genomics. 2009 Dec;4(2):119-30
pubmed: 20038499
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67
pubmed: 22505256
Expert Opin Drug Metab Toxicol. 2012 Apr;8(4):487-503
pubmed: 22335465
Biochim Biophys Acta. 2005 Aug 10;1751(2):119-39
pubmed: 16027053
Acta Crystallogr D Biol Crystallogr. 2015 Jan 1;71(Pt 1):36-44
pubmed: 25615858
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Nat Chem Biol. 2015 Oct;11(10):779-83
pubmed: 26322824
Expert Opin Drug Metab Toxicol. 2013 Feb;9(2):153-68
pubmed: 23231678
Appl Biochem Biotechnol. 2013 Feb;169(3):901-10
pubmed: 23292903
Proc Natl Acad Sci U S A. 2004 May 25;101(21):7931-6
pubmed: 15148401
Drug Metab Dispos. 2016 Aug;44(8):1277-85
pubmed: 26842593
FEBS J. 2009 May;276(10):2833-40
pubmed: 19459938
Drug Metab Dispos. 2012 May;40(5):856-64
pubmed: 22279051
J Biochem. 2002 Oct;132(4):597-606
pubmed: 12359075
FEBS J. 2015 Aug;282(16):3075-90
pubmed: 25817260
Arch Toxicol. 2016 Apr;90(4):753-80
pubmed: 26920149
Chem Rev. 2014 Apr 9;114(7):3963-4038
pubmed: 24467397
J Synchrotron Radiat. 2018 Jul 1;25(Pt 4):1249-1260
pubmed: 29979188
J Med Chem. 2010 Dec 23;53(24):8441-60
pubmed: 20853847
Anal Biochem. 2006 Oct 15;357(2):289-98
pubmed: 16962548
Drug Metab Rev. 2011 Aug;43(3):374-86
pubmed: 21428696
Protein Expr Purif. 2013 Oct;91(2):192-206
pubmed: 23948764
Structure. 2009 Nov 11;17(11):1505-14
pubmed: 19913485
J Am Chem Soc. 2012 Jan 18;134(2):999-1009
pubmed: 22145797
Drug Metab Pharmacokinet. 2015 Feb;30(1):52-63
pubmed: 25760530
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
PLoS One. 2017 Jul 27;12(7):e0182061
pubmed: 28750088
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14
pubmed: 23793146
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8846-51
pubmed: 8799115
J Org Chem. 2008 Dec 5;73(23):9469-72
pubmed: 18998731
Expert Opin Drug Metab Toxicol. 2014 Mar;10(3):379-93
pubmed: 24392841

Auteurs

Cristiano Mota (C)

UCIBIO, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal.

Mariam Esmaeeli (M)

Department of Molecular Enzymology, Institute of Biochemistry and Biology, University of Potsdam, Germany.

Catarina Coelho (C)

UCIBIO, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal.

Teresa Santos-Silva (T)

UCIBIO, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal.

Martin Wolff (M)

Department of Physical Biochemistry, Institute of Biochemistry and Biology, University of Potsdam, Germany.

Alessandro Foti (A)

Department of Molecular Enzymology, Institute of Biochemistry and Biology, University of Potsdam, Germany.

Silke Leimkühler (S)

Department of Molecular Enzymology, Institute of Biochemistry and Biology, University of Potsdam, Germany.

Maria João Romão (MJ)

UCIBIO, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH